Also trades as: 4547.T (JPX) · $vol 2M
KSPHF OTC
Kissei Pharmaceutical Co., Ltd.
1W: -2.4%
1M: -4.9%
3M: -4.9%
YTD: -9.2%
1Y: -19.1%
3Y: +35.8%
5Y: +25.6%
$24.50
-1.27 (-4.93%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1.5B
-122.9% ▼
Capital Expenditures
$4.9B
+2.3% ▲
5Y CAGR: +121.0%
Free Cash Flow
-$6.4B
-529.8% ▼
Dividends Paid
$4.9B
-28.2% ▼
Buybacks
$5.2B
+0.8% ▲
Net Change in Cash
-$22.1B
-1071.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $106M | $79M | $11.2B | $15.6B | $13.9B |
| Depreciation & Amort. | $31M | $31M | $4.3B | $4.6B | $4.7B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $772K | -$41M | -$9.3B | -$727M | -$1.5B |
| Other Non-Cash Items | $1.4B | -$6.7B | -$7.8B | -$13.0B | -$18.5B |
| Operating Cash Flow | $1.5B | -$6.7B | -$1.7B | $6.5B | -$1.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$47M | -$54M | -$1.2B | -$4.5B | -$5.7B |
| Acquisitions (Net) | $189K | $587K | $0 | $0 | $3.4B |
| Investment Purchases | -$47M | -$8M | -$2.4B | -$978M | -$2.1B |
| Investment Sales | $182M | $106M | $11.9B | $14.2B | $22.2B |
| Other Investing | $10.7B | $6.0B | $389M | -$3.7B | -$183M |
| Investing Cash Flow | $10.8B | $6.0B | $8.7B | $5.0B | $17.6B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$103M | -$150M | -$150M | -$60M | -$197M |
| Stock Repurchased | $0 | $0 | -$6.0B | -$5.3B | -$5.2B |
| Dividends Paid | -$2.5B | -$3.1B | -$3.7B | -$3.8B | -$4.9B |
| Other Financing | -$117M | -$135M | -$134M | -$171M | -$1M |
| Financing Cash Flow | -$2.8B | -$3.4B | -$10.0B | -$9.3B | -$10.3B |
| Net Change in Cash | $9.6B | $121M | -$3.0B | $2.3B | -$22.1B |
| Cash End of Period | $247M | $368M | $45.9B | $48.2B | $29.2B |
| Free Cash Flow | -$34M | -$105M | -$3.5B | $1.5B | -$6.4B |